Marketing authorisations: EU decentralised procedure—flowchart

Published by a UUÂãÁÄÖ±²¥ Life Sciences expert
Flowcharts

Marketing authorisations: EU decentralised procedure—flowchart

Published by a UUÂãÁÄÖ±²¥ Life Sciences expert

Flowcharts
imgtext

No medicinal product may be placed on the market unless it has been approved. This Flowchart outlines the procedure for obtaining an approval known as a marketing authorisation (MA) through the EU decentralised procedure.

The decentralised procedure is used to obtain MAs for medicinal products in more than one EU Member State in parallel. A medicine may only be authorised in individual Member States in parallel if it is not mandated to be authorised

Powered by Lexis+®
Jurisdiction(s):
United Kingdom

Popular documents